Wikidata entity: Q416975
C₆H₁₀N₆O (P274)
Quantities
| P2067 | mass | 182.0916 |
| P233 | canonical SMILES | String | CN(C)N=NC1=C(N=CN1)C(=O)N | ??? |
| P373 | Commons category | String | Dacarbazine | ??? |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CN(C)/N=N/C1=C(N=CN1)C(=O)N | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284157 (LiverTox toxicity likelihood category B) | LiverTox toxicity likelihood category B |
| P2175 | medical condition treated | ... | Q180614 (melanoma) | melanoma |
| P2175 | medical condition treated | ... | Q938205 (neuroblastoma) | neuroblastoma |
| P2175 | medical condition treated | ... | Q1362453 (fibrosarcoma) | fibrosarcoma |
| P2175 | medical condition treated | ... | Q1898141 (rhabdomyosarcoma) | rhabdomyosarcoma |
| P2175 | medical condition treated | ... | Q6084258 (islet cell carcinoma) | islet cell carcinoma |
| P2175 | medical condition treated | ... | Q6807316 (medullary carcinoma) | medullary carcinoma |
| P2175 | medical condition treated | ... | Q18557991 (Hodgkin's lymphoma, mixed cellularity) | Hodgkin's lymphoma, mixed cellularity |
| P2175 | medical condition treated | ... | Q18975788 (spindle cell sarcoma) | spindle cell sarcoma |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P279 | subclass of | ... | Q63088173 ((EZ)-dacarbazine) | (EZ)-dacarbazine |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q619908 (alkylating antineoplastic agent) | alkylating antineoplastic agent |
| P2868 | subject has role | ... | Q17172594 (alkylating agent) | alkylating agent |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | dacarbazine | ??? |
| P267 | ATC code | L01AX04 |
| P7524 | CA PROP 65 ID | dacarbazine |
| P683 | ChEBI ID | 177836 |
| P592 | ChEMBL ID | CHEMBL476 |
| P661 | ChemSpider ID | 10481959 |
| P715 | DrugBank ID | DB00851 |
| P11198 | DrugCentral ID | 773 |
| P232 | EC number | 224-396-1 |
| P2566 | ECHA Substance Infocard ID | 100.022.179 |
| P9635 | electronic Essential Medicines List medicine ID | 82 |
| P646 | Freebase ID | /m/08691l |
| P595 | Guide to Pharmacology Ligand ID | 9075 |
| P234 | InChI | InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)/b11-10+ |
| P235 | InChIKey | FDKXTQMXEQVLRF-ZHACJKMWSA-N |
| P665 | KEGG ID | D00288 |
| P7830 | LiverTox ID | Dacarbazine |
| P10245 | MedlinePlus drug identifier | a682750 |
| P486 | MeSH descriptor ID | D003606 |
| P672 | MeSH tree code | D02.925.200 |
| P672 | MeSH tree code | D03.383.129.308.240 |
| P6366 | Microsoft Academic ID (discontinued) | 2780964509 |
| P11901 | NCI Dictionary of Cancer Terms entry | dacarbazine |
| P2115 | NDF-RT ID | N0000146713 |
| P10283 | OpenAlex ID | C2780964509 |
| P4235 | PatientsLikeMe treatment ID | dacarbazine |
| P11199 | Probes And Drugs ID | PD002396 |
| P662 | PubChem CID | 135398738 |
| P1579 | Reaxys registry number | 521487 |
| P3345 | RxNorm CUI | 3098 |
| P5076 | Römpp online ID | RD-04-00015 |
| P2877 | SureChEMBL ID | 5560 |
| P2892 | UMLS CUI | C0010927 |
| P11089 | UniChem compound ID | 306556 |
| P652 | UNII | 7GR28W0FJI |
| P11143 | WikiProjectMed ID | Dacarbazine |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 3232 |
Why not click here or view trends?
log id: 3572371